IL17A and inflammatory bowel disease: Furthermore, TLR4 possibly activate down-stream JAK/STAT pathway to secrete IL-17A in inflammatory bowel disease [16], which suppressed WNT pathway through stimulating DKK1 in intestinal stem cells [17, 18].